Position in EYPT
as of Mar 31, 2026
· filed May 21, 2026
Position Value
$644,500
New position
Shares Held
50,000
first reported quarter
Ownership
0.060%
of shares outstanding
% of Portfolio
2.41%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Derivatives in EYPT
reported options exposure · as of Mar 31, 2026CallValue
$1,289,000
CallShares
100,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026SILVERBACK ASSET MANAGEMENT LLC holds $1,006,550 across 2 Biotechnology names. EYPT ranks #1 (64.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EYPT |
EyePoint, Inc.
This page
|
50,000 | $644,500 | |
| 2 | KPTI |
Karyopharm Therapeutics Inc.
|
65,000 | $362,050 |
All Filings in EYPT
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $644,500 | 50,000 | Shares | Sole | 2026-05-21 | |
| 2026-03-31 | $1,289,000 | 100,000 | Call | Sole | 2026-05-21 | |
| No filing history on record for this holder in this stock. | ||||||